| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.2B | $6.4B | $5.8B | $5.2B | $4.7B | $4.3B | $4.1B | $3.8B |
| Cost of Revenue | $9.1B | $8.2B | $7.4B | $6.9B | $6.1B | $5.3B | $5.2B | $4.7B |
| Gross Profit | $4.6B | $4.2B | $3.7B | $3.2B | $3.0B | $2.7B | $2.7B | $2.5B |
| R&D Expense | $1.6B | $1.5B | $1.4B | $1.5B | $1.2B | $1.0B | $1.0B | $0.9B |
| SG&A Expense | $8.7B | $7.7B | $7.1B | $6.5B | $6.4B | $5.4B | $5.4B | $5.1B |
| Operating Income | $4.9B | $3.7B | $3.9B | $2.8B | $2.6B | $2.2B | $2.7B | $2.5B |
| Net Income | $0.8B | $0.5B | $1.1B | $0.6B | $0.7B | $0.6B | $0.7B | $2.1B |
| EPS (Basic) | $2.21 | $1.43 | $3.01 | $1.48 | $1.75 | $1.51 | $1.94 | $5.52 |
| EPS (Diluted) | $2.20 | $1.41 | $2.98 | $1.47 | $1.73 | $1.49 | $1.90 | $5.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $47.8B | $43.0B | $39.9B | $36.9B | $34.6B | $34.3B | $30.2B | $27.2B |
| Current Assets | $14.8B | $14.8B | $12.5B | $10.3B | $10.0B | $9.7B | $11.4B | $9.7B |
| Cash & Equivalents | $4.0B | $3.7B | $3.0B | $1.8B | $2.9B | $2.9B | $4.3B | $3.6B |
| Total Liabilities | $25.4B | $22.3B | $21.3B | $20.3B | $19.8B | $21.2B | $17.4B | $15.5B |
| Current Liabilities | $7.8B | $7.6B | $7.9B | $6.3B | $4.5B | $5.0B | $4.4B | $4.8B |
| Stockholders' Equity | — | — | — | — | — | — | — | $11.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.0B | $4.2B | $3.7B | $2.6B | $3.3B | $3.3B | $2.2B | $2.6B |
| Investing Cash Flow | $-4.9B | $-3.0B | $-1.0B | $-2.9B | $-0.9B | $-4.7B | $-1.5B | $-2.9B |
| Capital Expenditures | $0.8B | $0.8B | $0.6B | $0.6B | $0.5B | $0.5B | $0.6B | $0.6B |
| Financing Cash Flow | $0.1B | $-0.5B | $-1.6B | $-0.7B | $-2.4B | $-0.0B | $0.0B | $1.3B |